Phlebitis and thrombophlebitis (not including DVT)

DOID EFO MESH SNOMED PheWeb

I9_PHLETHROM

Phlebitis: Inflammation of a vein.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 I80

Hospital discharge: ICD-9 4519X|4518X

Hospital discharge: ICD-8 451

Hospital discharge: excluded ICD-10 I80.20#, I80.29#, I80.3#

Hospital discharge: excluded ICD-8 4510

Cause of death: ICD-10 I80

Cause of death: ICD-9 4519X|4518X

Cause of death: ICD-8 451

Cause of death: excluded ICD-10 I80.20#, I80.29#, I80.3#

Cause of death: excluded ICD-8 4510

6095

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

5307

Check minimum number of events None

5307

Include endpoints None

5307

I9_PHLETHROM

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 I80-I89

Name in latin Phlebitis et thrombophlebitis

Similar endpoints

↥

List of similar endpoints to Phlebitis and thrombophlebitis (not including DVT) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5135	3022	2113
Unadjusted prevalence (%)	1.66	1.74	1.56
Mean age at first event (years)	57.93	56.34	60.20

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	3.76 [2.66, 5.33]	7.4e-14	622
15 years	0.01	1.52 [1.14, 2.03]	4.2e-3	194
5 years	0.00	4.26 [3.40, 5.34]	2.9e-36	210
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: I9_PHLETHROM – Phlebitis and thrombophlebitis (not including DVT)
GWS hits: 7

Survival analyses between endpoints

↥

Plot

before Phlebitis and thrombophlebitis (not including DVT)
after Phlebitis and thrombophlebitis (not including DVT)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Phlebitis and thrombophlebitis (not including DVT)

↥